Last update 21 Nov 2024
CPL2009-0031
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Sitagliptin fenilalanil |
Target |
Mechanism DPP-4 inhibitors(Dipeptidyl peptidase IV inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC25H25ClF6N6O2 |
InChIKeyLZDQVWZJBLFZSN-PXPMWPIZSA-N |
CAS Registry1339954-75-4 |
View All Structures (2)
Related
3
Clinical Trials associated with CPL2009-0031Prospective, Randomized, Double Blind, Parallel Group, Two Arm, Comparative, Multicenter, Clinical Study to Compare Efficacy and Safety of Oral CPL-2009-0031 140 mg of Cadila Pharmaceutical Limited, India Against Innovator Sitagliptin 100 mg in Patients With Uncontrolled Type-2 Diabetes Mellitus (T2DM)
Prospective, Randomized, Double Blinded, Parallel Group, Multicentric, ComparativeClinical study to compare efficacy and safety of oral CPL-2009-0031 of CadilaPharmaceutical Limited, India against innovator Sitagliptin in patients with UncontrolledType-2 Diabetes Mellitus (T2DM). - CPL-2009-0031
A safety, pharmacokinetics and pharmacodynamics study of CPL-2009-0031 in healthy volunteers and patients with Type 2 Diabetes mellitus (T2DM).
100 Clinical Results associated with CPL2009-0031
Login to view more data
100 Translational Medicine associated with CPL2009-0031
Login to view more data
100 Patents (Medical) associated with CPL2009-0031
Login to view more data
100 Deals associated with CPL2009-0031
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Phase 3 | - | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free